Previous 10 | Next 10 |
CINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has developed a series of innovative and high performing master mixes designed for manufa...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
CINCINNATI, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter fiscal 2021 financial results Friday, February 5, 2021. Jack Kenny, Chief Executive Officer, and...
Meridian could expand its testing supply windfall in 2021, as the world grapples with containing mutations of the COVID-19 virus. Balance sheet safety, profit margins, revenue growth, and current valuations are better than industry average. A large short interest position and a nu...
Gainers: [[VIVO]] +6%. [[ABUS]] +4.6%. [[AY]] +4.2%. [[EBON]] +3.5%. [[TSE]] +3.4%.Losers: [[ACLS]] -14%. [[DOGZ]] -8.5%. [[HX]] -7.8%. [[FIXX]] -5.9%. [[JRJC]] -2.1%. For further details see: AY, ABUS, ACLS and FIXX among after-hours movers
Meridian Bioscience ([[VIVO]] -2.0%) reported preliminary net revenue for Q1 of $92M compared to $47.4M a year ago, reflecting an increase of approximately 94% and better than consensus of $81.4M.Sees Life Science segment revenue of ~$62M, exceeding expectations due to the high demand fo...
CINCINNATI, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced preliminary financial results for the first quarter of fiscal 2021. Preliminary First Quarter Fiscal 2021 Res...
CINCINNATI, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the H. C. Wainright Bioconnect 2021 Virtual Conference. Jack Kenny, Chief Executive Officer,...
The seasonally-strongest baskets include gold and technology. The top stocks in each major sector right now. The best sectors include consumer goods, industrial goods, and financials. For further details see: The Top Stocks To Buy In The New Year
Meridian Bioscience ([[VIVO]] -3.3%) has been awarded funding of ~$1M by the National Institute of Health ((NIH)) Rapid Acceleration of Diagnostics initiative, to accelerate the launch of the company’s SARS-CoV-2 molecular diagnostic test on the Revogene platform.Recently,...
News, Short Squeeze, Breakout and More Instantly...
Meridian Bioscience Inc. Company Name:
VIVO Stock Symbol:
NASDAQ Market:
Meridian Bioscience Inc. Website:
The worldwide smartphone market has recently experienced a notable upturn in sales. October saw a 5% year-on-year growth, breaking a 27-...
Apple Inc. (NASDAQ:AAPL) has once again emerged as the most resilient smartphone maker in the world, reporting the slowest decline in iPhone shipme...
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...